Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garikapati Kusuma Kumari

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advanced Pharmaceutical Bulletin|April 8, 2024
ChatGPT in Drug Discovery ProcessAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Medical Oncology (Northwood, London, England)|May 19, 2021
Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancerGarikapati Kusuma Kumari, Ammu V V V Ravi Kiran, Praveen T Krishnamurthy
Investigational New Drugs|August 3, 2021
Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancerAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Advanced Pharmaceutical Bulletin|August 29, 2024
Translational Challenges in Cancer NanotherapyAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy, et al.
Biomaterials Science|October 21, 2021
Tumor microenvironment and nanotherapeutics: intruding the tumor fortAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy, et al.
Structural Chemistry|March 29, 2022
Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics studySuman Manandhar, K Sreedhara Ranganath Pai, Praveen T Krishnamurthy, et al.
Structural Chemistry|June 27, 2022
Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapySuman Manandhar, K Sreedhara Ranganath Pai, Praveen Thaggikuppe Krishnamurthy, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advanced Pharmaceutical Bulletin|April 8, 2024
ChatGPT in Drug Discovery ProcessAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Medical Oncology (Northwood, London, England)|May 19, 2021
Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancerGarikapati Kusuma Kumari, Ammu V V V Ravi Kiran, Praveen T Krishnamurthy
Investigational New Drugs|August 3, 2021
Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancerAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy
Advanced Pharmaceutical Bulletin|August 29, 2024
Translational Challenges in Cancer NanotherapyAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy, et al.
Biomaterials Science|October 21, 2021
Tumor microenvironment and nanotherapeutics: intruding the tumor fortAmmu V V V Ravi Kiran, Garikapati Kusuma Kumari, Praveen T Krishnamurthy, et al.
Structural Chemistry|March 29, 2022
Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics studySuman Manandhar, K Sreedhara Ranganath Pai, Praveen T Krishnamurthy, et al.
Structural Chemistry|June 27, 2022
Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapySuman Manandhar, K Sreedhara Ranganath Pai, Praveen Thaggikuppe Krishnamurthy, et al.
Pageof 1